Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Voyager Therapeutics (VYGR) Interest Expenses (2016)

Voyager Therapeutics (VYGR) has disclosed Interest Expenses for 2 consecutive years, with -$283000.0 as the latest value for Q2 2016.

  • Quarterly Interest Expenses fell 293.06% to -$283000.0 in Q2 2016 from the year-ago period, while the trailing twelve-month figure was -$283000.0 through Mar 2017, up 53.61% year-over-year, with the annual reading at $9.4 million for FY2015, 382.97% up from the prior year.
  • Interest Expenses hit -$283000.0 in Q2 2016 for Voyager Therapeutics, down from -$279000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $9.7 million in Q1 2015 to a low of -$283000.0 in Q2 2016.